|
2006, first semester results |
||||||
| Drug |
Total drug prescribing (mg) |
Total drug consuming (mg) |
Waste proportion (%) |
Negotiateda drug unit pricing (€/mg) |
Cost of consumed drugs (€) |
Drug waste cost (€) |
|
|
||||||
| Bleomycin |
0 |
0 |
0 |
1.19 |
0 |
0 |
| Carboplatin |
62975 |
63185 |
0.3 |
0.082 |
5181 |
17 |
| Cetuximab |
47940 |
49300 |
2.8 |
2.079 |
102495 |
2827 |
| Cyclophosphamide |
334314 |
356500 |
6.2 |
0.005 |
1782 |
111 |
| Cisplatin |
40664 |
42190 |
3.6 |
0.172 |
7257 |
262 |
| Dacarbazine |
42730 |
45700 |
6.5 |
0.023 |
1051 |
68 |
| Docetaxel |
15630 |
16500 |
5.3 |
7.525 |
124162 |
6547 |
| Doxorubicin |
11532 |
11880 |
3 |
1.46 |
17345 |
508 |
| Liposomial Doxorubicin. |
960 |
1090 |
12 |
17.69 |
19282 |
2300 |
| Epirubicin |
31350 |
31580 |
0.7 |
1.907 |
60223 |
439 |
| Etoposide |
11855 |
14200 |
16.5 |
0.022 |
312 |
52 |
| 5-fluorouracil |
2769077 |
3019370 |
8.3 |
0.002 |
6039 |
501 |
| Fotemustine |
1000 |
1040 |
3.8 |
2.15 |
2236 |
86 |
| Gemcitabine |
786330 |
802000 |
2 |
0.142 |
113884 |
2225 |
| Iphosphamide |
132050 |
137000 |
3.6 |
0.014 |
1918 |
69 |
| Irinotecan |
47995 |
48695 |
1.4 |
1.76 |
85703 |
1232 |
| Methotrexate |
9118 |
9700 |
6 |
0.055 |
533 |
32 |
| Mitomycin |
196.5 |
250 |
21.4 |
2.06 |
515 |
110 |
| Mitoxantrone |
15 |
20 |
25 |
5.39 |
108 |
27 |
| Oxaliplatin |
47033 |
49000 |
4 |
3.71 |
181790 |
7298 |
| Paclitaxel |
43932 |
43932 |
0 |
2.376 |
104382 |
0 |
| Pemetrexed |
26020 |
30000 |
13.3 |
2.54 |
76200 |
10109 |
| Raltitrexed |
37 |
42 |
11.9 |
62.5 |
2625 |
312 |
| Topotecan |
114 |
168 |
32.2 |
64.72 |
10873 |
3495 |
| Trastuzumab |
38433 |
41328 |
7 |
4.69 |
193828 |
13577 |
| Vinblastine |
25 |
20 |
25 |
0.991 |
20 |
5 |
| Vincristine |
20 |
22 |
9 |
2.09 |
46 |
4 |
| Vindesine |
50.5 |
65 |
22.3 |
20.78 |
1351 |
301 |
| Vinorelbine |
6718 |
6785 |
0.9 |
1.96 |
13299 |
131 |
| TOTAL |
4508114 |
4821562 |
6.5 |
1134440 |
52645 |
|
|
a2006 official hospital drug prices in Italy are available at [21] | ||||||
Fasola et al. BMC Health Services Research 2008 8:70 doi:10.1186/1472-6963-8-70 |
||||||